Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) filed a Form 8-K with the Securities and Exchange Commission on February 19, 2026, disclosing a material event.
Vanda Pharmaceuticals Inc.'s stock currently trades at $6.10 with a market capitalization of $390.0M. The Healthcare company's stock moved following the disclosure.